 reflect differences in
rates of actual and predicted decline in eGFR, in the competing risk of death, and in patient preferences.
In the United States, most patients who start dialysis do
not have a functioning permanent vascular access (autogenous or prosthetic) in place at the time dialysis is initiated, and
thus a catheter must be used for dialysis until permanent access
is placed and ready to be used.20,21 Many patients are not
referred